Pure Extracts Technologies Stock Return On Equity
Pure Extracts Technologies fundamentals help investors to digest information that contributes to Pure Extracts' financial success or failures. It also enables traders to predict the movement of Pure Pink Sheet. The fundamental analysis module provides a way to measure Pure Extracts' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pure Extracts pink sheet.
Pure |
Pure Extracts Technologies Company Return On Equity Analysis
Pure Extracts' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Pure Extracts Return On Equity | -1.39 |
Most of Pure Extracts' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pure Extracts Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Pure Extracts Technologies has a Return On Equity of -1.3885. This is 94.21% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is notably higher than that of the company.
Pure Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pure Extracts' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Pure Extracts could also be used in its relative valuation, which is a method of valuing Pure Extracts by comparing valuation metrics of similar companies.Pure Extracts is currently under evaluation in return on equity category among its peers.
Pure Fundamentals
| Return On Equity | -1.39 | |||
| Return On Asset | -0.41 | |||
| Profit Margin | (2.64) % | |||
| Operating Margin | (2.48) % | |||
| Current Valuation | 2.58 M | |||
| Shares Outstanding | 116.77 M | |||
| Shares Owned By Insiders | 1.18 % | |||
| Price To Book | 0.98 X | |||
| Price To Sales | 0.57 X | |||
| Revenue | 1.23 M | |||
| Gross Profit | (285.02 K) | |||
| EBITDA | (4.34 M) | |||
| Net Income | (5.24 M) | |||
| Cash And Equivalents | 245.08 K | |||
| Total Debt | 1.43 M | |||
| Debt To Equity | 0.38 % | |||
| Current Ratio | 1.25 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (2.8 M) | |||
| Earnings Per Share | (0.05) X | |||
| Beta | 3.5 | |||
| Market Capitalization | 1.3 M | |||
| Total Asset | 6.32 M | |||
| Net Asset | 6.32 M |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Pure Pink Sheet
If you are still planning to invest in Pure Extracts Techno check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pure Extracts' history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |